title: Recent advances in the molecular basis of anti-neoplastic mechanisms of oridonin.
abstract: Oridonin, a diterpenoid isolated from Rabdosia rubescens, has been proven to possess various pharmacological and physiological effects such as anti-inflammation, anti-bacterial, and anti-neoplastic, although in recent years, more attention has been paid to its anti-neoplastic effects. For example, oridonin can trigger cell cycle arrest, apoptosis, and autophagy in different neoplastic cell lines. This review summarizes the considerable knowledge about the action mechanisms of oridonin that has been studied in recent years. The present observations reveal the novel anti-neoplastic effects of oridonin, suggesting that it may be effective as a potent alternative or adjunct drug to conventional chemotherapy.
authors.affiliation: Department of Oncology, Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medcine, Shanghai 200092, China.
authors.forename: Wei
authors.initials: W
authors.lastname: Tian
authors.forename: Si-Yu
authors.initials: SY
authors.lastname: Chen
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000737:chemistry / Q000494:pharmacology* / Q000627:therapeutic use*; D017209:Apoptosis / Q000187:drug effects; D002453:Cell Cycle / Q000187:drug effects; D045786:Diterpenes, Kaurane / Q000009:adverse effects / Q000737:chemistry / Q000494:pharmacology* / Q000627:therapeutic use*; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy* / Q000473:pathology; D015398:Signal Transduction / Q000187:drug effects
chemical_list: D000970:Antineoplastic Agents; D045786:Diterpenes, Kaurane; C011959:oridonin
references.citation: Science. 1994 Dec 16;266(5192):1821-8
references.pmid: 7997877
references.citation: Int Immunopharmacol. 2007 Jul;7(7):945-54
references.pmid: 17499197
references.citation: Acta Pharmacol Sin. 2007 Nov;28(11):1819-26
references.pmid: 17959034
references.citation: Nat Rev Mol Cell Biol. 2007 Apr;8(4):275-83
references.pmid: 17380161
references.citation: Zhongguo Zhong Yao Za Zhi. 2006 Nov;31(21):1811-4
references.pmid: 17260801
references.citation: Biochem Biophys Res Commun. 2009 Jan 9;378(2):273-8
references.pmid: 19026988
references.citation: Int J Cancer. 1998 Sep 25;78(1):53-61
references.pmid: 9724094
references.citation: Ann Hematol. 2004 Nov;83(11):691-5
references.pmid: 15322762
references.citation: BMC Cancer. 2010 Nov 06;10:610
references.pmid: 21054888
references.citation: Nature. 2000 Oct 12;407(6805):796-801
references.pmid: 11048731
references.citation: Zhongguo Zhong Yao Za Zhi. 2005 Dec;30(23):1856-9
references.pmid: 16499027
references.citation: J Pharmacol Sci. 2006 Jul;101(3):230-9
references.pmid: 16861822
references.citation: Int J Lab Hematol. 2010 Feb;32(1 Pt 1):e114-22
references.pmid: 19302235
references.citation: FEBS J. 2009 Mar;276(5):1291-306
references.pmid: 19187231
references.citation: Arch Biochem Biophys. 2009 Oct 1;490(1):70-5
references.pmid: 19699177
references.citation: J Asian Nat Prod Res. 2008 Jan-Feb;10(1-2):77-87
references.pmid: 18058384
references.citation: Zhonghua Zhong Liu Za Zhi. 2008 Feb;30(2):89-92
references.pmid: 18646687
references.citation: Oncol Rep. 2010 Sep;24(3):647-51
references.pmid: 20664969
references.citation: Chem Pharm Bull (Tokyo). 2003 Jul;51(7):790-3
references.pmid: 12843583
references.citation: Zhonghua Wei Chang Wai Ke Za Zhi. 2009 Nov;12(6):607-10
references.pmid: 19921575
references.citation: Neoplasma. 2005;52(3):225-30
references.pmid: 15875084
references.citation: Biochem Biophys Res Commun. 2011 Aug 19;412(1):55-60
references.pmid: 21806968
references.citation: Arch Biochem Biophys. 2011 Jul;511(1-2):14-20
references.pmid: 21575590
references.citation: Biochim Biophys Acta. 1998 Aug 10;1366(1-2):139-49
references.pmid: 9714780
references.citation: Biochem Biophys Res Commun. 2005 Nov 11;337(1):224-31
references.pmid: 16176802
references.citation: Nat Prod Res. 2011 Sep;25(15):1402-11
references.pmid: 19606380
references.citation: Nature. 1994 May 26;369(6478):321-3
references.pmid: 8183370
references.citation: J Pharmacol Sci. 2008 Aug;107(4):370-9
references.pmid: 18719315
references.citation: Hepatol Res. 2006 Jun;35(2):104-10
references.pmid: 16638644
references.citation: Biochem Cell Biol. 1998;76(4):573-82
references.pmid: 10099777
references.citation: Pharmazie. 2007 Jun;62(6):439-44
references.pmid: 17663191
references.citation: Cancer Biol Ther. 2007 Feb;6(2):261-8
references.pmid: 17218775
references.citation: Leuk Lymphoma. 2005 Apr;46(4):593-7
references.pmid: 16019488
references.citation: Acta Pharmacol Sin. 2007 Jul;28(7):1057-66
references.pmid: 17588343
references.citation: Acta Pharmacol Sin. 2011 Oct;32(10):1266-75
references.pmid: 21892202
references.citation: Arch Biochem Biophys. 2009 Sep;489(1-2):25-33
references.pmid: 19646415
references.citation: Experientia. 1976 Feb 15;32(2):203-6
references.pmid: 1269612
references.citation: Phytomedicine. 2011 Jan 15;18(2-3):163-9
references.pmid: 20724128
references.citation: Int J Oncol. 2005 Mar;26(3):579-88
references.pmid: 15703811
references.citation: Cancer Lett. 2010 Aug 28;294(2):147-58
references.pmid: 20202741
references.citation: J Gastroenterol Hepatol. 2011 Apr;26(4):706-15
references.pmid: 21418301
references.citation: J Pharmacol Sci. 2007 Dec;105(4):317-25
references.pmid: 18094523
references.citation: Am J Hematol. 2006 Feb;81(2):86-94
references.pmid: 16432862
references.citation: Mol Cancer Ther. 2005 Apr;4(4):578-86
references.pmid: 15827331
references.citation: J Ethnopharmacol. 2006 Jan 16;103(2):176-80
references.pmid: 16169170
references.citation: Int J Oncol. 2003 Oct;23(4):1187-93
references.pmid: 12964003
references.citation: Zhonghua Yi Xue Za Zhi. 2010 Nov 16;90(42):2984-8
references.pmid: 21211311
references.citation: J Nat Prod. 2010 Jun 25;73(6):1058-63
references.pmid: 20496901